Merck Singapore M Lab collaboration center leverages ChromConnect initiative

On October 8, Singapore based Merck’s new M LabTM Collaboration Center brought Singapore's academic groups closer ...

October 8, 2022 | Saturday | News
Education vital to help patients explore gene therapies for blindness: Australian study

Australians with inherited retinal disease (IRD) have a strong interest in undergoing gene therapy to prevent and treat ...

October 7, 2022 | Friday | News
Hong Kong develops novel RNA nanoparticle for atherosclerosis treatment

A team of researchers at The Chinese University of Hong Kong (CUHK) has developed a novel RNA nanoparticle to offer a po...

October 6, 2022 | Thursday | News
Singapore pumps in SGD19.2 M for novel liver cancer treatment trial

A multi-national, investigator-initiated and industry-backed clinical trial has been launched to test the efficacy of a ...

October 6, 2022 | Thursday | News
MRFF backs Monash health and medical research with $28M in funding

The Australian Government’s Medical Research Future Fund (MRFF) has invested $28 million in funding for Monash res...

September 30, 2022 | Friday | News
New Zealand opens doorways for better diabetic heart health

Dr June-Chiew Han and fellow researchers from Waipapa Taumata Rau University of Auckland, New Zealand are looking closel...

September 30, 2022 | Friday | News
First Southeast Asian study to advance pulmonary hypertension early detection

MiRXES Pte Ltd, a Singapore-headquartered biotechnology company, has collaborated with National University Hea...

September 30, 2022 | Friday | News
Biosyngen boosts cell therapy GMP capabilities in Singapore

Singapore-based startup Biosyngen has signed to set up a cell therapy GMP facility which will serve as a base to develop...

September 28, 2022 | Wednesday | News
Australia developing new tools to improve diagnosis, treatment of blood cancer

Australian scientists will use new technology to improve the diagnosis and treatment of blood cancers, which affect 1.24...

September 27, 2022 | Tuesday | News
Cynata Therapeutics gets $1 M grant to develop heart disease treatment

Cynata Therapeutics has announced that the Australian Government National Health and Medical Research Council (NHMRC) ha...

September 28, 2022 | Wednesday | News
Singapore awards NRF grant to develop novel therapies for liver cancer

A team of multidisciplinary scientists has been awarded the prestigious National Research Foundation (NRF) Singapo...

September 21, 2022 | Wednesday | News
Singapore identifies role of 'harmless' bacteria in worsening lung diseases

A team of international scientists led by the Nanyang Technological University, Singapore (NTU Singapore) has discovered...

September 20, 2022 | Tuesday | News
Australia's EpiAxis Therapeutics partners with University Health Newtork to study prostate cancer

Australian firm EpiAxis Therapeutics, a leading epigenetics company with a focus on cancer treatment and prevention recu...

September 20, 2022 | Tuesday | News
Singapore opens Centre for Microbiome Medicine to improve human health

Nanyang Technological University, Singapore (NTU Singapore) has launched the Centre for Microbiome Medici...

September 15, 2022 | Thursday | News
Korea establishes novel strategy to tackle Huntington's disease​

Through an international joint research effort involving ProQR Therapeutics of the Netherlands, Université Grenob...

September 13, 2022 | Tuesday | News
Stem cells could be key to slowing ageing process: New Zealand study

A “serendipitous finding” by a team of researchers at the University of Auckland, New Zealand could shed lig...

September 8, 2022 | Thursday | News
Polyplus Builds on Research and Commercial mRNA Support Portfolio with in vivo-jetRNA®+ Transfection Reagent

The new in vivo-jetRNA®+ transfection reagent an efficient, stable, and safe delivery system leading to 100% mR...

September 8, 2022 | Thursday | News
Singapore sets up world's first integrated pre-clinical & clinical ageing research institute

The National University Health System (NUHS) has established the NUHS Centre for Healthy Longevity &...

September 7, 2022 | Wednesday | News
Australian startup OccuRx secures $16 M to progress therapies for inflammation, fibrosis

Australian biotech startup OccuRx has announcesd a $16 million cash injection to progress into clinical phase studies fo...

September 7, 2022 | Wednesday | News
Global pandemic therapeutics centre to open in Australia

The establishment of the Cumming Global Centre for Pandemic Therapeutics has been announced by the University of Melbour...

September 5, 2022 | Monday | News
India develops novel virus-like particle to combat COVID-19 & variants

A team of researchers at the Indian Institute of Science (IISc) have developed and tested a novel virus-like particle (V...

September 2, 2022 | Friday | News
China leads research of world's first spatiotemporal map of brain regeneration

A multi-institute research team led by China-based BGI Group has used BGI Stereo-seq technology to construct the world f...

September 2, 2022 | Friday | News
NZ leads world in trial of futuristic therapy

A treatment that works at the gene level to solve the root cause of a genetic disease will soon be tested at the Unive...

September 1, 2022 | Thursday | News
Hong Kong identifies innovative strategy for treatment of Alzheimer's disease

An international research team, led by Prof. Nancy IP, The Morningside Professor of Life Science at the Hong Kong Univer...

August 30, 2022 | Tuesday | News
National Genome Project in Indonesia picks MGI as technology provider

MGI Tech, based in China, has announced that the National Genome Project in Indonesia has selected MGI technol...

August 25, 2022 | Thursday | News